ITW — Illinois Tool Works Inc.

As of 2026-08-27, the market has digested the July 28 Q2 beat—record operating margin, EPS of $2.84, and raised guidance—plus the August 7 7% dividend increase and $6B buyback authorization. The stock is still below its 52-week high of $303.16, and Street positioning is cautious: 13 holds, 9 sells, 6 buys, with a consensus target of $280.71, almost exactly at the current price. Constructive fundamentals plus cautious analyst sentiment net out to Neutral.

The trend is clearly inflecting higher. Revenue was roughly flat-to-soft through 2024 and early 2025 (Q1 2025 revenue was $3.84B), then accelerated: Q4 2025 grew 4.1% YoY, Q1 2026 grew 4.6%, and Q2 2026 grew 6.1% to $4.30B with 4.5% organic growth. Excluding the non-repeatable 2024 Q3 EPS spike of $3.91, diluted EPS improved from the $2.38–$2.58 range in 2025 to $2.66 and $2.84 in the first two quarters of 2026. Operating margin hit a record 26.7% in Q2 2026, up ~40 bps YoY, and Q2 operating cash flow jumped to $723M from $550M a year earlier. This is an acceleration, not a one-quarter blip.

As of 2026-08-27, ITW is not cheap: trailing P/E is 25.49 versus the 5-year average of 24.63, and forward P/E is about 24.6 on consensus 2026 EPS of $11.43. Price-to-sales of 4.92 is slightly above the 5-year average of 4.76, and the reported PEG of -7.7 is meaningless; using forward EPS growth of roughly 9%, the growth-adjusted multiple is still rich. Price-to-book of 27.9 is distorted by buyback-depleted equity and should be ignored. The dividend yield of 2.38% helps, but the valuation is fair-to-full, not a bargain.

On 2026-08-27, the $281.67 price is essentially at the analyst consensus target of $280.71 and about 24.6x forward EPS of $11.43. That means the market is pricing in steady execution—not a major acceleration. If management hits the midpoint of its raised 2026 EPS guidance of $11.45 and the multiple holds near 25x, the stock is worth roughly $286. If organic growth fades below 3% and the multiple compresses to 22x, a $250 handle is realistic. The risk/reward is balanced around the current quote.

As of 2026-08-27, RSI 14 was 46.16, so the stock is neither overbought nor oversold. Price is 2.45% below the 20-day SMA, 0.87% above the 50-day SMA, and 5.87% above the 200-day SMA. That is a short-term pullback within a longer-term uptrend, not a breakdown. For entry timing, there is no compelling oversold signal; patient buyers might look for a retest near the 50-day around $279 or a convincing close back above the 20-day near $289.

• Elevated interest rates continue to pressure consumer-facing and residential-adjacent end markets such as auto OEM and construction, but heavy-industrial, infrastructure, electronics, and testing demand is offsetting the softness.
• Reshoring, automation, and electronics/capex cycles are tailwinds for ITW's Welding and Test & Measurement & Electronics segments, which posted double-digit organic growth.
• Persistent input-cost inflation is being offset by ITW's 80/20 enterprise strategy, contributing around 120 bps of margin improvement.
• Mixed global manufacturing PMI data means ITW's 4.5% organic growth is company-specific strength, but a broader industrial recession would still hit volumes and make the current multiple harder to defend.

• Q3 2026 earnings on October 23, 2026, with consensus EPS around $2.95; a beat and maintained/raised guidance would likely push the stock toward the high end of its range.
• Pace and execution of the newly authorized $6B share repurchase program, plus the 7% dividend increase, should provide a floor under the stock.
• Further recovery in automotive OEM or residential construction end-markets if interest rates ease would broaden the growth base.
• Continued double-digit growth in Welding and Test & Measurement & Electronics, aided by reshoring and automation spending, is the main fundamental upside driver.

• Valuation risk: at ~25x trailing earnings and ~24.6x forward earnings, the stock has limited cushion for an organic-growth miss; the analyst roster already includes 9 sell ratings.
• Cyclical exposure: auto OEM and construction end-markets remain soft, and a broader industrial downturn would hit revenue and margins simultaneously.
• Balance-sheet leverage is elevated relative to equity because of aggressive buybacks—debt-to-equity is 3.35 and the current ratio is only 1.11—limiting financial flexibility in a downturn.
• Earnings quality needs watching: the deterministic score shows a slightly positive accrual ratio (0.56%), meaning reported net income is marginally ahead of operating cash flow; not a red flag yet, but worth monitoring.

ITW is a high-quality compounder with record operating margins, improving organic growth, strong free cash flow, and clear shareholder-return support from the buyback and dividend increase. But at ~25x earnings with a consensus target roughly equal to the current price, the upside is not compelling enough to chase. It is a reasonable core holding, and new money is better deployed on a pullback rather than at the current quote.

I applied a justified forward P/E of 25.0x to management's 2026 EPS guidance midpoint of $11.45. The 25.0x multiple is a modest premium to ITW's 5-year average P/E of 24.63, reflecting its record operating margin and 24.5% ROIC, but tempered by modest ~3.5% organic growth and elevated leverage. That yields a fair value of $286.25.